The risk of cardiovascular disease death is decreased with a single 3-in-1 medication.
Researchers from Spain created a polypill that lowers the risk of stroke and cardiovascular death by 33%. The term "polypill" refers to the drug "Trinomia," which mixes numerous cardiac drugs into a single pill. The use of a polypill "resulted in a significantly decreased risk of major adverse cardiovascular events than normal therapy," according to studies that followed patients who were recuperating from a heart attack.
What's in the pill, exactly?
After a patient has recovered from a heart attack, doctors frequently prescribe several drugs to ward off further heart issues in the future. These cardiovascular treatments often consist of three drugs: an aspirin-like blood thinner, a statin that lowers cholesterol, and an ACE inhibitor that lowers blood pressure. One pill containing all...